The American Journal of Medicine
Volume 122, Issue 2 , Pages 109-113 , February 2009

Asthma in US Seniors: Part 2. Treatment. Seeing Through the Glass Darkly

  • Richard D. deShazo, MD

      Affiliations

    • Divisions of Clinical Immunology-Allergy and Geriatrics, Department of Medicine, University of Mississippi Medical Center, Jackson
    • Corresponding Author InformationRequests for reprints should be addressed to Richard D. deShazo, MD, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216
    • ,
  • J. Eric Stupka, MD

      Affiliations

    • Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Texas Health Sciences Center at San Antonio, San Antonio

References 

  1. National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Heart, Lung, and Blood Institute; 1991;(NIH Publication No. 91-3642)
  2. National Asthma Education and Prevention Program. Expert Panel Report II: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Heart, Lung, and Blood Institute; 1997;(NIH Publication No. 97-4051)
  3. National Asthma Education and Prevention Program. Expert Panel Report Update: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Heart, Lung, and Blood Institute; 2002;(NIH Publication No. 02-5074)
  4. National Asthma Education and Prevention Program. Expert Panel Report III: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Heart, Lung, and Blood Institute; 2007;(NIH Publication No. 08-4051)
  5. National Asthma Education and Prevention Program. Working Group Report: Considerations for Diagnosis and Managing Asthma in the Elderly. Bethesda, MD: National Institute of Heart, Lung and Blood Institute; 1996;(NIH Publication No 96-3662)
  6. Sitar D, Aoki F, Warren C, et al. A placebo-controlled dose-finding study with bambuterol in elderly patients with asthma. Chest. 1993;103:771–776
  7. Horiguchi T, Tachikawa S, Kondo R, et al. Comparative evaluation of the leukotriene receptor antagonists pranlukast versus the steroid inhalant fluticasone in the therapy of aged patients with mild bronchial asthma. Arzneimittelforschung. 2007;57:87–91
  8. Donateo L, Gerardi R, Cantini L. A new spacer device for administration of inhaled salbutamol: use in elderly asthmatics. Adv Ther. 1996;13:292–300
  9. Dyer C, Singh S, Stockley R, Sinclair A, Hill S. The incremental shuttle walking test in elderly people with chronic airflow limitation. Thorax. 2002;57:34–38
  10. Enright P, McClelland R, Newman A, et al. Underdiagnosis and undertreatment of asthma in the elderly. Chest. 1999;116:603–613
  11. Connolly M, Crowley J, Charan N, et al. Reduced subjective awareness of bronchoconstriction provoked by methacholine in elderly asthmatic and normal subjects as measured on a simple awareness scale. Thorax. 1992;47:410–413
  12. Kronenberg R, Drage C. Attenuation of the ventilatory and heart rate responses to hypoxia and hypercapnia with aging in normal men. J Clin Invest. 1973;52:1812–1819
  13. Brischetto M, Millman R, Peterson D, et al. Effect of aging on ventilatory response to exercise and CO2. J Appl Physiol. 1984;1143–1150
  14. Vergnenegre A, Antonini M, Bonnaud F, et al. Comparison between late onset and childhood asthma. Allergol Immunopathol. 1992;20:190–196
  15. Inman W. Monitoring of adverse reactions to drugs in the United Kingdom. Proc R Soc Med. 1970;63:1302–1304
  16. Robin E, McCauley R. Sudden cardiac death in bronchial asthma and inhaled beta-adrenergic agonists. Chest. 1992;101:1699–1702
  17. Salpeter S, Ormiston T, Salpeter E. Cardiovascular effects of B-agonists in patients with asthma and COPD: a meta-analysis. Chest. 2004;125:2309–2321
  18. Nelson H, Weiss S, Bleecker E, et al. The salmeterol multicenter asthma research trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest. 2006;129:15–26
  19. Donohue J. Therapeutic responses in asthma and COPD: bronchodilators. Chest. 2004;126:125–137
  20. Westby M, Benson M, Gibson P. Anticholinergic agents for chronic asthma in adults. Cochrane Database Syst Rev. 2004;3:CD003269
  21. Rodrigo G, Castro-Rodriguez J. Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis. Thorax. 2005;60:740–746
  22. Sin D, Tu J. Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164:580–584
  23. Leone F, Fish J, Szefler S, West S. Systematic review of the evidence regarding potential complications of inhaled corticosteroid use in asthma: collaboration of American College of Chest Physicians, American Academy of Allergy, Asthma and Immunology, and American College of Allergy, Asthma and Immunology. Chest. 2003;124:2329–2340
  24. Garbe E, LeLorier J, Boivin J, Suissa S. Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma. JAMA. 1997;277:722–727
  25. Garbe E, Suissa S, LeLorier J. Association of inhaled corticosteroid use with cataract extraction in elderly patients. JAMA. 1998;280:539–543
  26. Sin D, Tu J. Underuse of inhaled steroid therapy in elderly patients with asthma. Chest. 2001;119:720–725
  27. Korenblat P, Kemp J, Scherger J, et al. Effect of age on response to zafirlukast in patients with asthma in the Accolate Clinical Experience and Pharmacoepidemiology Trial (ACCEPT). Ann Allergy Asthma Immunol. 2000;84:217–225
  28. Bousquet J, Cabrera P, Berkman N, et al. The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma. Allergy. 2005;60:302–308
  29. Ho S, O'Mahony MS, Steward J, et al. Inhaler technique in older people in the community. Age Ageing. 2004;33:185–188
  30. Goodman D, Israel E, Rosenberg M, et al. The influence of age, diagnosis, and gender on proper use of metered-dose inhalers. Am J Respir Crit Care Med. 1994;150:1256–1261
  31. Brockelbank D, Ram F, Wright J, et al. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature. Health Technol Assess. 2001;5:1–149
  32. Dolovich M, Ahrens R, Hess D, et al. Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy and Immunology. Chest. 2005;127:335–371
  33. Allen S. Competence thresholds for the use of inhalers in people with dementia. Age Ageing. 1997;26:83–86

 Funding: none.

 Conflict of Interest: none.

PII: S0002-9343(08)00899-1

doi: 10.1016/j.amjmed.2008.09.019

The American Journal of Medicine
Volume 122, Issue 2 , Pages 109-113 , February 2009

Article Tools